Alcoholic liver disease

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406

Changes of Intestinal Functions in Liver Cirrhosis

Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820

The AUDIT Alcohol Consumption Questions (AUDIT-C)<subtitle>An Effective Brief Screening Test for Problem Drinking</subtitle>

Bush, K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1789 · Cited by 6,196

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821

AASLD guidelines for the treatment of hepatocellular carcinoma

Heimbach, J. K., Kulik, L., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2017) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,107

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870

Mechanisms of hepatic stellate cell activation

Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219

The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD

Cheng, Z., Yang, L., & Chu, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.002 · Cited by 40

Structure characteristics of a novel pectic polysaccharide from Fructus Corni and its protective effect on alcoholic fatty liver

Bai, H.-X., Gao, Y., Wang, S., Ma, G.-Y., Zhao, W., Li, X., Wang, Y., Nong, Q.-N., Wang, Y., Tan, J. H., et al. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.123153 · Cited by 40

Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease

Wu, H., Chen, J., Guo, S., Deng, J., Zhou, Z., Zhang, X., Qi, T., Yu, F., & Yang, Q. L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2500099 · Cited by 42

Human Gut Microbiome and Liver Diseases: From Correlation to Causation

Li, R., Mao, Z., Ye, X., & Zuo, T. (2021) · Microorganisms · doi:10.3390/microorganisms9051017 · Cited by 40

Effects of Anthraquinones on Immune Responses and Inflammatory Diseases

Xin, D., Li, H., Zhou, S., Zhong, H., & Pu, W. (2022) · Molecules · doi:10.3390/molecules27123831 · Cited by 43

Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism

Thomes, P. G., Rasineni, K., Li, Y., Donohue, T. M., Kubik, J. L., McNiven, M. A., & Casey, C. A. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00376.2018 · Cited by 39

Severe alcoholic hepatitis: current perspectives

Philips, C. A., Augustine, P., Yerol, P. K., Rajesh, S., & Mahadevan, P. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s197933 · Cited by 39

P2X7 receptor‐targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage–hepatocyte crosstalk

Zhang, Y., Jiang, M., Cui, B., Jin, C. H., Wu, Y., Shang, Y., Yang, H., Wu, M., Liu, J., Qiao, C., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15007 · Cited by 39

Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2

Liu, N., Liu, M., Jiang, M., Li, Z., Chen, W., Wang, W., Fu, X., Qi, M., Ali, M. H., Zou, N., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114173 · Cited by 39

Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease

Litwinowicz, K., & Gamian, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032461 · Cited by 38

Lipid peroxidation derived reactive aldehydes in alcoholic liver disease

Ali, H., Assiri, M. A., Shearn, C. T., & Fritz, K. S. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2018.10.003 · Cited by 38

Diagnostic biomarkers in liver injury by drugs, herbs, and alcohol: Tricky dilemma after EMA correctly and officially retracted letter of support

Teschke, R., Eickhoff, A., Brown, A. C., Neuman, M. G., & Schulze, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010212 · Cited by 30

Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking

Li, N., Liu, H. S., Xue, Y., Xu, Z., Miao, X., Guo, Y., Li, Z., Fan, Z., & Xu, Y. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216592 · Cited by 38

When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis

Ferdek, P. E., Krzysztofik, D., Stopa, K. B., Kusiak, A. A., Paw, M., Wnuk, D., & Jakubowska, M. J. (2022) · The Journal of Physiology · doi:10.1113/jp281135 · Cited by 38

Hepatic pIgR-mediated secretion of IgA limits bacterial translocation and prevents ethanol-induced liver disease in mice

Hendrikx, T., Lang, S., Rajcic, D., Wang, Y., McArdle, S., Kim, K., Mikulski, Z., & Schnabl, B. (2023) · Gut · doi:10.1136/gutjnl-2022-328265 · Cited by 37

Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives

Yan, M., Man, S., Ma, L., Guo, L., Huang, L., & Gao, W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0315 · Cited by 39

Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment

Liu, Y., Yang, H., Li, T. X., & Zhang, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460282 · Cited by 39

Polyunsaturated fatty acid-induced metabolic exhaustion and ferroptosis impair the anti-tumour function of MAIT cells in MASLD

Deschler, S., Pohl, J., Ramsauer, L., Meiser, P., Erlacher, S., Schenk, R. P., Maurer, H. C., Shen, P., Kager, J., Zink, J., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.06.006 · Cited by 41

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease

Jung, F., Burger, K., Staltner, R., Brandt, A., Mueller, S., & Bergheim, I. (2021) · Nutrients · doi:10.3390/nu13051659 · Cited by 37

Bile Acid–Mediated Activation of Brown Fat Protects From Alcohol-Induced Steatosis and Liver Injury in Mice

Fan, M., Wang, Y., Jin, L., Fang, Z., Peng, J., Tu, J., Liu, Y., Zhang, E., Xu, S., Liu, X., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.001 · Cited by 39

Kinsenoside Alleviates Alcoholic Liver Injury by Reducing Oxidative Stress, Inhibiting Endoplasmic Reticulum Stress, and Regulating AMPK-Dependent Autophagy

Gao, L., Chen, X., Fu, Z., Yin, J., Wang, Y., Sun, W., Ren, H. G., & Zhang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.747325 · Cited by 37

Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects

Ferrao, K., Ali, N., & Mehta, K. J. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02254-8 · Cited by 40

Management of alcoholic hepatitis: A clinical perspective

Kasper, P., Lang, S., Steffen, H., & Demir, M. (2023) · Liver International · doi:10.1111/liv.15701 · Cited by 36

Ginseng-derived nanoparticles alleviate alcohol-induced liver injury by activating the Nrf2/HO-1 signalling pathway and inhibiting the NF-κB signalling pathway in vitro and in vivo

Li, W., Yang, S., Zhao, Y., Nunzio, G. D., Ren, L., Fan, L., Zhao, R., Zhao, D., & Wang, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155428 · Cited by 43

Interleukin-22 in alcoholic hepatitis and beyond

Xiang, X., Hwang, S., Feng, D., Shah, V. H., & Gao, B. (2020) · Hepatology International · doi:10.1007/s12072-020-10082-6 · Cited by 36

Liver Metabolomics Reveals the Effect of Lactobacillus reuteri on Alcoholic Liver Disease

Zheng, T., Pu, S.-L., Tan, P., Du, Y., Qian, B., Chen, H., Fu, W., & Huang, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.595382 · Cited by 36

Hylocereus polyrhizus Peel Extract Retards Alcoholic Liver Disease Progression by Modulating Oxidative Stress and Inflammatory Responses in C57BL/6 Mice

Yeh, W.-J., Tsai, C.-C., Ko, J., & Yang, H. (2020) · Nutrients · doi:10.3390/nu12123884 · Cited by 36

Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress

Jiang, Z., Gao, J., Chai, Y., Li, W., Luo, Y., & Chen, Y. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12390 · Cited by 35

Transcriptome analysis reveals the hepatoprotective mechanism of soybean meal peptides against alcohol-induced acute liver injury mice

Pan, F., Cai, Z., Ge, H., Ma, S., Yu, Y., Liu, J., & Zhang, T. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112353 · Cited by 36

Iron deficiency and biomarkers of inflammation: a 3-year prospective analysis of the DO-HEALTH trial

Wieczorek, M., Schwarz, F., Sadlon, A., Abderhalden, L. A., Molino, C. D. G. R. C., Spahn, D. R., Schaer, D. J., Orav, E. J., Egli, A., & Bischoff-Ferrari, H. A. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01955-3 · Cited by 36

Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications

Wang, C., Liu, J., Yan, Y., & Tan, Y. (2022) · Journal of Immunology Research · doi:10.1155/2022/1695802 · Cited by 37

Verbenalin attenuates hepatic damage and mitochondrial dysfunction in alcohol-associated steatohepatitis by regulating MDMX/PPARα-mediated ferroptosis

Dong, J., Du, C., Xu, C., Wang, Q., Wang, Z., Zeng, F., Qian, Z., Zhang, L., Lv, X., Lei, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116227 · Cited by 35

Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome

Kim, H., Choi, Y. J., Kim, S. K., Kim, H., Jun, D. W., Yoon, K., Kim, N., Hwang, J., Kim, Y. M., Lim, S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02345-1 · Cited by 35

Efficacy of Phyllanthus niruri on improving liver functions in patients with alcoholic hepatitis

Sowjanya, K., Girish, C., Bammigatti, C., & Lakshmi, N. C. P. (2021) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_540_20 · Cited by 35

Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis

Wu, J., Wen, L., Liu, X., Li, Q., Sun, Z., Liang, C., Xie, F., & Li, X. (2024) · Phytotherapy Research · doi:10.1002/ptr.8347 · Cited by 35

The beneficial effects of taurine in alleviating fatty liver disease

Song, Q., Guo, J., Zhang, Y., & Chen, W. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104351 · Cited by 34

Sinapic Acid Reduces Oxidative Stress and Pyroptosis via Inhibition of BRD4 in Alcoholic Liver Disease

Chu, J., Yan, R., Wang, S., Li, G., Kang, X., Hu, Y. W., Lin, M., Shan, W., Zhao, Y., Wang, Z., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.668708 · Cited by 34

H2O2-mediated autophagy during ethanol metabolism

Chen, C., Wang, S., Yu, L., Mueller, J. H., Fortunato, F., Rausch, V., & Mueller, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102081 · Cited by 35

Gut non-bacterial microbiota contributing to alcohol-associated liver disease

Gao, W., Zhu, Y., Ye, J., & Chu, H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1984122 · Cited by 35

A Peptide HEPFYGNEGALR from Apostichopus japonicus Alleviates Acute Alcoholic Liver Injury by Enhancing Antioxidant Response in Male C57BL/6J Mice

Zhu, Q., Zhuo, H., Yang, L., Ouyang, H., Chen, J., Liu, B., & Huang, H. (2022) · Molecules · doi:10.3390/molecules27185839 · Cited by 34

Intestinal epithelial β Klotho is a critical protective factor in alcohol-induced intestinal barrier dysfunction and liver injury

Hou, Z., Ding, Q., Li, Y., Zhao, Z., Yan, F., Li, Y., Wang, X., Xu, J., Chen, W., Wu, G., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104181 · Cited by 32

Protective Effect of Polyphenols, Protein, Peptides, and Polysaccharides on Alcoholic Liver Disease: A Review of Research Status and Molecular Mechanisms

Wang, W., Xu, C., Wang, Q., Hussain, M. A., Wang, C., Hou, J., & Jiang, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07081 · Cited by 33

Effect of Hepatic Pathology on Liver Regeneration: The Main Metabolic Mechanisms Causing Impaired Hepatic Regeneration

Rodimova, S. A., Mozherov, A. M., Elagin, V. V., Karabut, M. M., Shchechkin, I. D., Kozlov, D., Krylov, D. P., Gavrina, A. I., Bobrov, N., Загайнов, В. Е., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119112 · Cited by 34

Monofloral Triadica Cochinchinensis Honey Polyphenols Improve Alcohol-Induced Liver Disease by Regulating the Gut Microbiota of Mice

Luo, L., Zhang, J., Liu, M., Qiu, S., Yi, S., Yu, W., Liu, T., Huang, X., & Ning, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673903 · Cited by 35

Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease

Hernández‐Tejero, M., Clemente, A. P. G., & Bataller, R. A. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.10.002 · Cited by 33

Hepatoprotective effects of a traditional Chinese medicine formula against carbon tetrachloride-induced hepatotoxicity in vivo and in vitro

Ren, X., Xin, L.-T., Zhang, M., Zhao, Q. C., Yue, S.-Y., Chen, K., Guo, Y., Shao, C., & Wang, C. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109190 · Cited by 33

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives

Zhang, Z., Yang, H., Han, F., & Guo, P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060464 · Cited by 37

Therapeutic modulation methods of gut microbiota and gut-liver axis

Coşkun, A. B., & Celep, G. S. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1902263 · Cited by 32

Synthetic Retinoids Beyond Cancer Therapy

Gudas, L. J. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-104428 · Cited by 34

Genistein Protects against Acetaldehyde-Induced Oxidative Stress and Hepatocyte Injury in Chronic Alcohol-Fed Mice

Ding, Q., Pi, A., Hao, L., Xu, T., Zhu, Q., Shu, L., Yu, X., Wang, W., Si, C., & Li, S. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05747 · Cited by 32

A decade of liver organoids: Advances in disease modeling

Liu, Y., Sheng, J.-Y., Yang, C.-F., Ding, J., & Chan, Y.-S. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0428 · Cited by 30

Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis

Li, G., Chen, H.-Q., Shen, F., Smithson, S. B., Shealy, G. L., Ping, Q., Liang, Z., Han, J., Adams, A. C., Li, Y., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000433 · Cited by 30

A promising therapy for fatty liver disease: PCSK9 inhibitors

Han, L., Wu, L., Yin, Q., Li, L., Zheng, X., Du, S., Huang, X., Bai, L., Wang, Y., & Bian, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155505 · Cited by 31

Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder

Lohoff, F. W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.767506 · Cited by 37

Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases

Wen, Y., Ma, L., & Ju, C. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100020 · Cited by 31

Lutein Prevents Liver Injury and Intestinal Barrier Dysfunction in Rats Subjected to Chronic Alcohol Intake

Zhao, S., Zhang, Y., Ding, H., Hu, S., Wu, X., Ma, A., & Ma, Y. (2023) · Nutrients · doi:10.3390/nu15051229 · Cited by 33

Porphyromonas gingivalis exacerbates alcoholic liver disease by altering gut microbiota composition and host immune response in mice

Gao, Y., Zhang, P., Wei, Y., Ye, C., Mao, D., Xia, D., & Luo, Y. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13833 · Cited by 30

Kaempferol stimulation of autophagy regulates the ferroptosis under the oxidative stress as mediated with AMP-activated protein kinase

Kim, M., Song, Y.-R., Kim, Y. E., Bae, S.-J., Lee, W.-Y., Bak, S. B., & Kim, Y. W. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.008 · Cited by 31

The Interplay of Inflammatory Processes and Cognition in Alcohol Use Disorders—A Systematic Review

Coppens, V., Morrens, M., Destoop, M., & Dom, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00632 · Cited by 31

Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease

Cai, Q., Gan, C., Tang, C., Wu, H. M., & Gao, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.784591 · Cited by 31

The role of gut microbiota in clinical complications, disease severity, and treatment response in severe alcoholic hepatitis

Philips, C. A., Augustine, P., Ganesan, K., Ranade, S., Chopra, V., Patil, K. N., Shende, S., Ahamed, R., Kumbar, S. V., Rajesh, S. K., et al. (2022) · Indian Journal of Gastroenterology · doi:10.1007/s12664-021-01157-9 · Cited by 31

Hydrogen gas ameliorates acute alcoholic liver injury via anti-inflammatory and antioxidant effects and regulation of intestinal microbiota

Liu, H., Kang, X., Ren, P., Kuang, X., Yang, X., Yang, H., Shen, X., Yan, H., Kang, Y., Zhang, F., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110252 · Cited by 30

Pueraria Extract Ameliorates Alcoholic Liver Disease via the Liver–Gut–Brain Axis: Focus on Restoring the Intestinal Barrier and Inhibiting Alcohol Metabolism

Wu, Q., Li, P., Li, X., Ma, L., Chen, K., & Man, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c05365 · Cited by 30

Helicobacter hepaticus infection induces chronic hepatitis and fibrosis in male BALB/c mice via the activation of NF‐κB, Stat3, and MAPK signaling pathways

Cao, S., Zhu, C. X., Feng, J., Zhu, L., Yin, J., Xu, Y., Yang, H., Huang, Y., & Zhang, Q. (2019) · Helicobacter · doi:10.1111/hel.12677 · Cited by 30

Metabolomics Study of Serum from a Chronic Alcohol-Fed Rat Model Following Administration of Defatted Tenebrio molitor Larva Fermentation Extract

Choi, R., Ji, M., Lee, M., & Paik, M. (2020) · Metabolites · doi:10.3390/metabo10110436 · Cited by 29

Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice

Momen‐Heravi, F., Catalano, D. E., Talis, A., Szabó, G., & Bala, S. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.05.007 · Cited by 29

Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity

Fujimoto, Y., Kaji, K., Nishimura, N., Enomoto, M., Murata, K., Takeda, S., Takaya, H., Kawaratani, H., Moriya, K., Namisaki, T., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i48.8323 · Cited by 29

Six Types of Tea Reduce Acute Alcoholism in Mice by Enhancing Ethanol Metabolism, Suppressing Oxidative Stress and Inflammation

Lai, X., Wang, X., Wen, S., Sun, L., Chen, R., Zhang, Z., Li, Q., Cao, J., Lai, Z., Li, Z., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.848918 · Cited by 29

Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis

Mueller, S., Chen, C., Mueller, J. H., & Wang, S. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0056 · Cited by 30

Gut microbiome and nonalcoholic fatty liver disease

Wu, M., & Fan, J. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.06.006 · Cited by 32

Megamitochondria plasticity: Function transition from adaption to disease

Shang, Y., Li, Z., Cai, P., Li, W., Xu, Y., Zhao, Y., Xia, S., Shao, Q., & Wang, H. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.06.001 · Cited by 28

Effect of silymarin on the relative gene expressions of some inflammatory cytokines in the liver of CCl4-intoxicated male rats

El-Kot, S. M., Wanas, W., Hafez, A. M., Mahmoud, N. A., Tolba, A. M. A., Younis, A. H., Elsayed, T. G., & Abdelwahab, H. E. (2023) · Scientific Reports · doi:10.1038/s41598-023-42250-7 · Cited by 28

Protective Effects and Mechanism of Polysaccharides from Edible Medicinal Plants in Alcoholic Liver Injury: A Review

Su, Z., Yan, T.-Y., Feng, J., Zhang, M., Han, L., Zhang, H., & Xiao, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216530 · Cited by 28

The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease

Scarlata, G. G. M., Colaci, C., Scarcella, M., Dallio, M., Federico, A., Boccuto, L., & Abenavoli, L. (2024) · Diseases · doi:10.3390/diseases12040069 · Cited by 27

Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR

Lin, L., Xu, S., Wang, W., Li, X., Wang, H., Yang, Q., Wang, C., Gu, J., Luo, H., & Meng, Q. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155693 · Cited by 28

The role of taurine through endoplasmic reticulum in physiology and pathology

Wang, L., Xie, Z., Wu, M., Chen, Y., Wang, X., Li, X., & Liu, F. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116386 · Cited by 32

P-Hydroxyacetophenone Ameliorates Alcohol-Induced Steatosis and Oxidative Stress via the NF-κB Signaling Pathway in Zebrafish and Hepatocytes

Huang, S., Zhou, C., Zeng, T., Li, Y., Lai, Y., Mo, C., Chen, Y., Huang, S., Lv, Z., & Gao, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01594 · Cited by 28

Genetic variant rs72613567 of HSD17B13 gene reduces alcohol‐related liver disease risk in Chinese Han population

Chen, H., Zhang, Y., Guo, T., Yang, F., Mao, Y., Li, L., Liu, C., Gao, H., Jin, Y., Che, Y., et al. (2020) · Liver International · doi:10.1111/liv.14616 · Cited by 27

Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns

Beier, J. I., & Arteel, G. E. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.005 · Cited by 29

Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease

Warner, J. B., Guenthner, S. C., Hardesty, J., McClain, C. J., Warner, D. R., & Kirpich, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i36.5280 · Cited by 31

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review

Odriozola, A., Santos‐Laso, Á., Barrio, M. D., Cabezas, J., Iruzubieta, P., Arias, M., Rivas, C., Duque, J. C. R., Antón, Á., Fábrega, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097791 · Cited by 29

The role of lipins in innate immunity and inflammation

Balboa, M. A., de Pablo, N., Meana, C., & Balsinde, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.06.003 · Cited by 31

Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical

Boyer‐Díaz, Z., Morata, P., Aristu-Zabalza, P., Gibert‐Ramos, A., Bosch, J., & Gracia‐Sancho, J. (2020) · Nutrients · doi:10.3390/nu12092627 · Cited by 28

Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice

Zhu, L., Cao, F., Hu, Z., Zhou, Y., Guo, T., Yan, S., Xie, Q., Xia, X., Yuan, H., Li, G., et al. (2024) · Nutrients · doi:10.3390/nu16050694 · Cited by 29

Postbiotics Prepared Using Lactobacillus reuteri Ameliorates Ethanol‐Induced Liver Injury by Regulating the FXR/SHP/SREBP‐1c Axis

Liu, C., Cai, T., Cheng, Y., Bai, J., Li, M., Gu, B., Huang, M., & Fu, W. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300927 · Cited by 27

Elucidating hydroxysafflor yellow A's multi-target mechanisms against alcoholic liver disease through integrative pharmacology

Yu, H., Bai, Q.-R., Guo, J.-J., Chen, M.-Y., Wang, L., Tong, F.-C., Zhang, S., & Wu, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155956 · Cited by 27

Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis

Yang, J., Yang, L., Wang, Y., Huai, L. F., Shi, B., Zhang, D., Xu, W., & Cui, D. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01089-6 · Cited by 28

An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice

Díaz, L. A., Ajmera, V. H., Arab, J. P., Huang, D. Q., Hsu, C. L., Lee, B. P., Louvet, A., Thiele, M. S., Tavaglione, F., Tincopa, M. A., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.02.017 · Cited by 28

Imaging alkaline phosphatase activity in alcoholic liver disease via a rational-designed NIR fluorogenic probe

Ding, G., Ma, X., Wang, L., Tuo, Q., Wang, J., Liu, J. B., & Zhang, J. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2026.127459 · Cited by 27

Hepatotoxicity study of combined exposure of DEHP and ethanol: A comprehensive analysis of transcriptomics and metabolomics

Li, Y., Zhang, Q., Fang, J., Ma, N., Geng, X., Xu, M., Yang, H., & Jia, X. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111370 · Cited by 27

Advancements in the Alcohol-Associated Liver Disease Model

Zhu, L., Li, H.-D., Xu, J., Li, J., Cheng, M., Meng, X., Huang, C., & Li, J. (2022) · Biomolecules · doi:10.3390/biom12081035 · Cited by 30

Echinacoside from Cistanche tubulosa ameliorates alcohol‐induced liver injury and oxidative stress by targeting Nrf2

Ding, Y., Zhang, Y., Wang, Z., Zeng, F., Zhen, Q., Zhao, H., Li, J., Ma, T., & Huang, C. (2023) · The FASEB Journal · doi:10.1096/fj.202201430r · Cited by 27

Promising derivatives of rutaecarpine with diverse pharmacological activities

Li, D., Huang, Z., Xu, X., & Li, Y. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1199799 · Cited by 26

Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application

Su, L., Bu, J., Yu, J., Jin, M., Meng, G., & Zhu, X. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70066 · Cited by 27

Embelin improves alcoholic steatohepatitis in alcohol-associated liver disease via ATF6-mediated P2X7r-NLRP3 signaling pathway

Zhang, J., Zhong, J., Wang, W., Wang, S.-Y., Guo, X., Sun, H., & Song, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156638 · Cited by 28

Hepatoprotective Effects ofMorchella esculentaagainst Alcohol-Induced Acute Liver Injury in the C57BL/6 Mouse Related to Nrf-2 and NF-κB Signaling

Meng, B., Zhang, Y., Wang, Z., Ding, Q., Song, J. M., & Wang, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6029876 · Cited by 27

Mucosal-Associated Invariant T cell in liver diseases

Zhang, Y., Kong, D., & Wang, H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.39016 · Cited by 26

Persistent deficiency of mucosa-associated invariant T (MAIT) cells during alcohol-related liver disease

Zhang, Y., Fan, Y., He, W., Han, Y., Bao, H., Yang, R., Wang, B., Kong, D., & Wang, H. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00664-8 · Cited by 26

Liver Organoids: Updates on Disease Modeling and Biomedical Applications

Caiazza, C., Parisi, S., & Caiazzo, M. (2021) · Biology · doi:10.3390/biology10090835 · Cited by 28

DRAM1 increases the secretion of PKM2-enriched EVs from hepatocytes to promote macrophage activation and disease progression in ALD

Tan, J., Zhang, J., Wang, M., Wang, Y., Dong, M., Ma, X., Sun, B., Liu, S., Zhao, Z., Chen, L., et al. (2022) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2021.12.017 · Cited by 26

Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments

Argemí, J., Cots, M. V., Rachakonda, V. P., & Bataller, R. A. (2020) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2020.7242/2020 · Cited by 26

Alcohol-related liver disease

Idalsoaga, F. J., Singal, A. K., Arrese, M. A., & Arab, J. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-87031-3.00032-9

Diagnosis and Management of Alcoholic Liver Disease

Dugum, M. F., & McCullough, A. J. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00008 · Cited by 79

Alcoholic liver disease (ALD)

Hartleb, M., & Czech, E. K. (2007) · Cited by 2

Alcoholic Liver Disease: Diagnosis and Treatment Strategies

Mohajan, H. K. (2024) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2024.12.06 · Cited by 2